Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A15099 | 29097281 | Biochimie | Steatosis and NASH in type 2 diabetes. | 2017 | Details |
| A15106 | 29091299 | Hepatology | Hepatic leukocyte immunoglobulin-like receptor B4 (LILRB4) attenuates nonalcoholic fatty liver disease via SHP1-TRAF6 pathway. | 2018 | Details |
| A15109 | 29090431 | J Endocrinol Invest | Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients. | 2017 | Details |
| A15121 | 29085434 | Evid Based Complement Alternat Med | Effect of Seyoeum on Obesity, Insulin Resistance, and Nonalcoholic Fatty Liver Disease of High-Fat Diet-Fed C57BL/6 Mice. | 2017 | Details |
| A15122 | 29085222 | World J Gastroenterol | Intrahepatic vascular changes in non-alcoholic fatty liver disease: Potential role of insulin-resistance and endothelial dysfunction. | 2017 | Details |
| A15123 | 29085206 | World J Gastroenterol | Nonalcoholic fatty liver disease: Evolving paradigms. | 2017 | Details |
| A15141 | 29077210 | Hepatology | Hepatocyte DUSP14 maintains metabolic homeostasis and suppresses inflammation in the liver. | 2018 | Details |
| A15145 | 29074727 | Gut | Liver Reptin/RUVBL2 controls glucose and lipid metabolism with opposite actions on mTORC1 and mTORC2 signalling. | 2017 | Details |
| A15147 | 29074597 | Diabetes | S-Nitrosoglutathione Reductase Dysfunction Contributes to Obesity-Associated Hepatic Insulin Resistance via Regulating Autophagy. | 2017 | Details |
| A15150 | 29073130 | PLoS One | Non-alcoholic fatty liver disease and the development of nephrolithiasis: A cohort study. | 2017 | Details |
| A15151 | 29073114 | Proc Natl Acad Sci U S A | Pathogenesis of hypothyroidism-induced NAFLD is driven by intra- and extrahepatic mechanisms. | 2017 | Details |
| A15157 | 29069580 | Eur J Pharmacol | Nicotinamide prevents sweet beverage-induced hepatic steatosis in rats by regulating the G6PD, NADPH/NADP+ and GSH/GSSG ratios and reducing oxidative and inflammatory stress. | 2017 | Details |
| A15158 | 29067443 | Mol Med Rep | Role of ADAMTS13 in diet-induced liver steatosis. | 2017 | Details |
| A15162 | 29066788 | Sci Rep | Periodontal pathogenic bacteria, Aggregatibacter actinomycetemcomitans affect non-alcoholic fatty liver disease by altering gut microbiota and glucose metabolism. | 2017 | Details |
| A15163 | 29066462 | Am J Physiol Endocrinol Metab | Genetic ablation of Cyp8b1 preserves host metabolic function by repressing steatohepatitis and altering gut microbiota composition. | 2017 | Details |
| A15167 | 29065507 | Nutrients | Fatty Acids Consumption: The Role Metabolic Aspects Involved in Obesity and Its Associated Disorders. | 2017 | Details |
| A15169 | 29065431 | Horm Metab Res | Liver Fat Content in People with Pituitary Diseases: Influence of Serum IGF1 Levels. | 2017 | Details |
| A15174 | 29063908 | Am J Gastroenterol | Adherence to Mediterranean Diet and Non-Alcoholic Fatty Liver Disease: Effect on Insulin Resistance. | 2017 | Details |
| A15176 | 29063072 | Chronic Dis Transl Med | Potential role of thymosin beta 4 in the treatment of nonalcoholic fatty liver disease. | 2017 | Details |
| A15195 | 29055928 | Ann Hepatol | New Onset Diabetes and Non-Alcoholic Fatty Liver Disease after Liver Transplantation. | 2018 | Details |
| A15197 | 29055919 | Ann Hepatol | The Expression of PNPLA3 Polymorphism could be the Key for Severe Liver Disease in NAFLD in Hispanic Population. | 2018 | Details |
| A15203 | 29051986 | Osteoporos Int | The relationship between fatty liver index and bone mineral density in Koreans: KNHANES 2010-2011. | 2017 | Details |
| A15204 | 29051770 | Nutr Metab (Lond) | Serum alanine aminotransferase/aspartate aminotransferase ratio is one of the best markers of insulin resistance in the Chinese population. | 2017 | Details |
| A15208 | 29049354 | PLoS One | Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States. | 2017 | Details |
| A15210 | 29046007 | Dtsch Med Wochenschr | [Dietary Recommendations in Metabolic Vascular Syndrome]. | 2017 | Details |
| A15223 | 29037210 | Lipids Health Dis | A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease. | 2017 | Details |
| A15225 | 29036913 | Molecules | Alpha-Galacto-Oligosaccharides at Low Dose Improve Liver Steatosis in a High-Fat Diet Mouse Model. | 2017 | Details |
| A15228 | 29035308 | Nutrients | Gut Microbiota and Nonalcoholic Fatty Liver Disease: Insights on Mechanisms and Therapy. | 2017 | Details |
| A15229 | 29035092 | Crit Rev Food Sci Nutr | Vitamin D supplementation and non-alcoholic fatty liver disease: A critical and systematic review of clinical trials. | 2017 | Details |
| A15233 | 29031724 | Mol Metab | Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease. | 2017 | Details |
| A15237 | 29028831 | PLoS One | Short-term vitamin E treatment impairs reactive oxygen species signaling required for adipose tissue expansion, resulting in fatty liver and insulin resistance in obese mice. | 2017 | Details |
| A15241 | 29027424 | Zhongguo Zhong Yao Za Zhi | [Research progress on therapeutic targets of active components in Chinese herbs for treatment of nonalcoholic fatty liver disease]. | 2017 | Details |
| A15246 | 29025206 | Ann Pediatr Endocrinol Metab | Nonalcoholic fatty liver disease in long-term survivors of childhood-onset craniopharyngioma. | 2017 | Details |
| A15247 | 29024899 | Biomed Pharmacother | Mangiferin ameliorates fatty liver via modulation of autophagy and inflammation in high-fat-diet induced mice. | 2017 | Details |
| A15248 | 29024702 | Metabolism | Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences. | 2017 | Details |
| A15253 | 29023387 | Nutrients | Combination of β-glucan and Morus alba L. Leaf Extract Promotes Metabolic Benefits in Mice Fed a High-Fat Diet. | 2017 | Details |
| A15254 | 29023319 | Eur J Gastroenterol Hepatol | Comparison of fenofibrate and pioglitazone effects on patients with nonalcoholic fatty liver disease. | 2017 | Details |
| A15269 | 28993156 | Diabetes Res Clin Pract | Association between hemoglobin glycation index and hepatic steatosis in non-diabetic individuals. | 2017 | Details |
| A15270 | 28993096 | Transl Res | Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells. | 2017 | Details |
| A15272 | 28991837 | J Pediatr Gastroenterol Nutr | Serum Osteocalcin Levels in Children With Nonalcoholic Fatty Liver Disease. | 2018 | Details |
| A15274 | 28990251 | J Gastroenterol Hepatol | Waist-to-calf circumstance ratio is an independent predictor of hepatic steatosis and fibrosis in patients with type 2 diabetes. | 2018 | Details |
| A15283 | 28987868 | Redox Biol | Impairment of Akt activity by CYP2E1 mediated oxidative stress is involved in chronic ethanol-induced fatty liver. | 2017 | Details |
| A15284 | 28987323 | Pharmacol Ther | The longevity gene INDY (I'm Not Dead Yet) in metabolic control: Potential as pharmacological target. | 2017 | Details |
| A15285 | 28987260 | Clin Liver Dis | Treatment Strategies for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis. | 2017 | Details |
| A15288 | 28986308 | Biochim Biophys Acta Mol Basis Dis | n-3 Fatty acids combined with flavan-3-ols prevent steatosis and liver injury in a murine model of NAFLD. | 2017 | Details |
| A15289 | 28985579 | Eur J Cancer | Metformin and insulin impact on clinical outcome in patients with advanced hepatocellular carcinoma receiving sorafenib: Validation study and biological rationale. | 2017 | Details |
| A15293 | 28982243 | J Agric Food Chem | Solanum nigrum Polyphenol Extracts Inhibit Hepatic Inflammation, Oxidative Stress, and Lipogenesis in High-Fat-Diet-Treated Mice. | 2017 | Details |
| A15295 | 28981167 | Acta Paediatr | Serum complement factor 5a levels are associated with nonalcoholic fatty liver disease in obese children. | 2017 | Details |
| A15297 | 28980219 | Curr Environ Health Rep | Persistent Endocrine-Disrupting Chemicals and Fatty Liver Disease. | 2017 | Details |
| A15300 | 28975492 | Obes Surg | Sleeve Gastrectomy Outcomes in Patients with BMI Between 30 and 35-3 Years of Follow-Up. | 2018 | Details |
| A15301 | 28974844 | Med Arch | Effects of Azilsartan, Aliskiren or their Combination on High Fat Diet-induced Non-alcoholic Liver Disease Model in Rats. | 2017 | Details |
| A15307 | 28972537 | J Clin Invest | Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling. | 2017 | Details |
| A15308 | 28972487 | Georgian Med News | EFFECT THE CARDIOMETABOLIC RISK FACTORS ON VASCULAR AGING IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE CONCOMITANT WITH SUBCLINICAL HYPOTHYROIDISM. | 2017 | Details |
| A15311 | 28971838 | Am J Physiol Gastrointest Liver Physiol | Hyperglucagonemia correlates with plasma levels of non-branched-chain amino acids in patients with liver disease independent of type 2 diabetes. | 2017 | Details |
| A15313 | 28970836 | Front Immunol | Fructose: A Dietary Sugar in Crosstalk with Microbiota Contributing to the Development and Progression of Non-Alcoholic Liver Disease. | 2017 | Details |
| A15329 | 28965028 | Diabetes Res Clin Pract | Angiopoietin-like protein 8: An attractive biomarker for the evaluation of subjects with insulin resistance and related disorders. | 2017 | Details |
| A15332 | 28964678 | Dig Liver Dis | Fat accumulates preferentially in the right rather than the left liver lobe in non-diabetic subjects. | 2017 | Details |
| A15340 | 28956824 | Nutrients | Translational Aspects of Diet and Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15341 | 28956816 | Nutrients | Qualitative and Quantitative Evaluation of Dietary Intake in Patients with Non-Alcoholic Steatohepatitis. | 2017 | Details |
| A15343 | 28955746 | Biochem Biophys Rep | Scaffold-free 3D bio-printed human liver tissue stably maintains metabolic functions useful for drug discovery. | 2017 | Details |
| A15353 | 28951211 | Biochim Biophys Acta Mol Basis Dis | MicroRNA-194 inhibition improves dietary-induced non-alcoholic fatty liver disease in mice through targeting on FXR. | 2017 | Details |
| A15357 | 28948002 | Oncotarget | Linking atrial fibrillation with non-alcoholic fatty liver disease: potential common therapeutic targets. | 2017 | Details |
| A15358 | 28947922 | Clin Epigenetics | Diabetes medication associates with DNA methylation of metformin transporter genes in the human liver. | 2017 | Details |
| A15363 | 28945101 | DNA Cell Biol | Implications of Sortilin in Lipid Metabolism and Lipid Disorder Diseases. | 2017 | Details |
| A15366 | 28942551 | J Endocrinol Invest | Androgen excess and metabolic disorders in women with PCOS: beyond the body mass index. | 2017 | Details |
| A15368 | 28942436 | Horm Mol Biol Clin Investig | The color of fat and its central role in the development and progression of metabolic diseases. | 2017 | Details |
| A15369 | 28942246 | Free Radic Biol Med | Inhibition of hepatocyte nuclear factor 1b induces hepatic steatosis through DPP4/NOX1-mediated regulation of superoxide. | 2017 | Details |
| A15371 | 28941598 | Metabolism | Energy-matched moderate and high intensity exercise training improves nonalcoholic fatty liver disease risk independent of changes in body mass or abdominal adiposity - A randomized trial. | 2017 | Details |
| A15372 | 28941597 | Metabolism | Immunomodulatory liposomes targeting liver macrophages arrest progression of nonalcoholic steatohepatitis. | 2017 | Details |
| A15374 | 28940752 | Mol Nutr Food Res | Supplementation with Docosahexaenoic Acid and Extra Virgin Olive Oil Prevents Liver Steatosis Induced by a High-Fat Diet in Mice through PPAR-α and Nrf2 Upregulation with Concomitant SREBP-1c and NF-kB Downregulation. | 2017 | Details |
| A15375 | 28940700 | Hepatology | Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis. | 2018 | Details |
| A15378 | 28938455 | J Clin Endocrinol Metab | Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese Subjects. | 2017 | Details |
| A15383 | 28936403 | J Clin Transl Hepatol | Non-alcoholic Fatty Liver Disease in Lean Subjects: Characteristics and Implications. | 2017 | Details |
| A15393 | 28932090 | World J Gastroenterol | New botanical drug, HL tablet, reduces hepatic fat as measured by magnetic resonance spectroscopy in patients with nonalcoholic fatty liver disease: A placebo-controlled, randomized, phase II trial. | 2017 | Details |
| A15396 | 28931589 | J Nutr | Oral Supplementation of Glutamine Attenuates the Progression of Nonalcoholic Steatohepatitis in C57BL/6J Mice. | 2017 | Details |
| A15397 | 28931435 | Lipids Health Dis | Circulating retinol binding protein 4 levels in nonalcoholic fatty liver disease: a systematic review and meta-analysis. | 2017 | Details |
| A15403 | 28928235 | Am J Physiol Endocrinol Metab | Testosterone protects high-fat/low-carbohydrate diet-induced nonalcoholic fatty liver disease in castrated male rats mainly via modulating endoplasmic reticulum stress. | 2017 | Details |
| A15404 | 28927302 | Scand J Gastroenterol | IGFBP-1 and IGF-I as markers for advanced fibrosis in NAFLD - a pilot study. | 2017 | Details |
| A15407 | 28926951 | Nutrients | Insights into the Hexose Liver Metabolism-Glucose versus Fructose. | 2017 | Details |
| A15409 | 28925934 | J Clin Med | Can Diet Help Non-Obese Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD)? | 2017 | Details |
| A15411 | 28925124 | Zhongguo Zhong Yao Za Zhi | [Effects of lotus leaf on inflammatory factors and liver AdipoR2 expressions in rats with NAFLD induced by high fat diet and high glucose]. | 2016 | Details |
| A15413 | 28924233 | Sci Rep | Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD. | 2017 | Details |
| A15421 | 28922096 | J Am Coll Nutr | The Effects of Ramadan Fasting on Body Composition, Blood Pressure, Glucose Metabolism, and Markers of Inflammation in NAFLD Patients: An Observational Trial. | 2017 | Details |
| A15429 | 28918389 | J Investig Med | Glucagon like peptide-1 receptor agonists for the management of obesity and non-alcoholic fatty liver disease: a novel therapeutic option. | 2017 | Details |
| A15430 | 28918170 | Clin Nutr | Lifestyle predictors of obese and non-obese patients with nonalcoholic fatty liver disease: A cross-sectional study. | 2017 | Details |
| A15436 | 28913408 | Cell Mol Gastroenterol Hepatol | Hepatocyte-Specific Deletion of Mouse Lamin A/C Leads to Male-Selective Steatohepatitis. | 2017 | Details |
| A15438 | 28906453 | Nutrients | Vitamin D Supplementation and Non-Alcoholic Fatty Liver Disease: Present and Future. | 2017 | Details |
| A15441 | 28905319 | J Physiol Biochem | PI3K inhibition protects mice from NAFLD by down-regulating CMKLR1 and NLRP3 in Kupffer cells. | 2017 | Details |
| A15443 | 28904866 | FEBS Open Bio | IMM-H007, a new therapeutic candidate for nonalcoholic fatty liver disease, improves hepatic steatosis in hamsters fed a high-fat diet. | 2017 | Details |
| A15444 | 28904022 | FASEB J | PI3Kγ ablation does not promote diabetes in db/db mice, but improves insulin sensitivity and reduces pancreatic β-cell apoptosis. | 2017 | Details |
| A15448 | 28902430 | J Bone Miner Res | Reduced Serum IGF-1 Associated With Hepatic Osteodystrophy Is a Main Determinant of Low Cortical but Not Trabecular Bone Mass. | 2017 | Details |
| A15451 | 28900935 | Adv Exp Med Biol | Metabolic Disorders and Cancer: Hepatocyte Store-Operated Ca2+ Channels in Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A15454 | 28899857 | Am J Physiol Endocrinol Metab | High-fat, high-fructose, high-cholesterol feeding causes severe NASH and cecal microbiota dysbiosis in juvenile Ossabaw swine. | 2017 | Details |
| A15456 | 28899715 | J Steroid Biochem Mol Biol | The relationship between 25-hydroxyvitamin D concentration and liver enzymes in overweight or obese adults: Cross-sectional and interventional outcomes. | 2017 | Details |
| A15457 | 28898507 | Liver Int | Growth differentiation factor 15 predicts advanced fibrosis in biopsy-proven non-alcoholic fatty liver disease. | 2017 | Details |
| A15459 | 28895929 | Nutrients | Effects of Oral Administration of Silymarin in a Juvenile Murine Model of Non-alcoholic Steatohepatitis. | 2017 | Details |
| A15465 | 28894517 | Middle East J Dig Dis | Effects of Probiotic and Prebiotic Supplementation on Leptin, Adiponectin, and Glycemic Parameters in Non-alcoholic Fatty Liver Disease: A Randomized Clinical Trial. | 2017 | Details |
| A15466 | 28894050 | Postepy Hig Med Dosw (Online) | Compounds of psoriasis with obesity and overweight. | 2017 | Details |
| A15467 | 28892924 | J Clin Diagn Res | Comparison of Pioglitazone and Metformin Efficacy against Glucocorticoid Induced Atherosclerosis and Hepatic Steatosis in Insulin Resistant Rats. | 2017 | Details |
| A15470 | 28892211 | Pediatr Int | Early menarche is associated with non-alcoholic fatty liver disease in adulthood. | 2017 | Details |